These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 11574355
21. [Prophylaxis of nausea and vomiting after pelviscopy. Dolasetron or MCP in comparison with placebo]. Rüsch D, Bernhardt J, Wulf H. Anaesthesist; 1999 Oct; 48(10):705-12. PubMed ID: 10551919 [Abstract] [Full Text] [Related]
23. The effect of anaesthetic technique on postoperative nausea and vomiting after day-case gynaecological laparoscopy. Paech MJ, Lee BH, Evans SF. Anaesth Intensive Care; 2002 Apr; 30(2):153-9. PubMed ID: 12002921 [Abstract] [Full Text] [Related]
24. Dexamethasone in combination with dolasetron for prophylaxis in the ambulatory setting: effect on outcome after laparoscopic cholecystectomy. Coloma M, White PF, Markowitz SD, Whitten CW, Macaluso AR, Berrisford SB, Thornton KC. Anesthesiology; 2002 Jun; 96(6):1346-50. PubMed ID: 12170046 [Abstract] [Full Text] [Related]
25. Ondansetron versus dolasetron: a comparison study in the prevention of postoperative nausea and vomiting in patients undergoing gynecological procedures. Browning BA, Fort CA, Kemp KD, Shimata MF, Strube MD. AANA J; 2004 Apr; 72(2):129-32. PubMed ID: 15098526 [Abstract] [Full Text] [Related]
26. Dolasetron for the prevention of postoperative vomiting in children undergoing strabismus surgery. Wagner D, Pandit U, Voepel-Lewis T, Weber M. Paediatr Anaesth; 2003 Jul; 13(6):522-6. PubMed ID: 12846709 [Abstract] [Full Text] [Related]
27. Comparison of oral dolasetron and ondansetron in the prophylaxis of postoperative nausea and vomiting in children. Karamanlioglu B, Turan A, Memis D, Süt N. Eur J Anaesthesiol; 2003 Oct; 20(10):831-5. PubMed ID: 14580054 [Abstract] [Full Text] [Related]
28. Randomized, double-blind trial of dolasetron versus droperidol for prophylaxis of postoperative nausea and vomiting in patients undergoing TRAM flap breast reconstruction surgery. Loewen P, Lamb S, Clugston P. Ann Plast Surg; 2003 Nov; 51(5):472-7. PubMed ID: 14595183 [Abstract] [Full Text] [Related]
29. Inspired oxygen fraction of 0.8 compared with 0.4 does not further reduce postoperative nausea and vomiting in dolasetron-treated patients undergoing laparoscopic cholecystectomy. Piper SN, Röhm KD, Boldt J, Faust KL, Maleck WH, Kranke P, Suttner SW. Br J Anaesth; 2006 Nov; 97(5):647-53. PubMed ID: 16963789 [Abstract] [Full Text] [Related]
30. The effect of timing of ondansetron administration in outpatients undergoing otolaryngologic surgery. Sun R, Klein KW, White PF. Anesth Analg; 1997 Feb; 84(2):331-6. PubMed ID: 9024023 [Abstract] [Full Text] [Related]
31. Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group. Hesketh P, Navari R, Grote T, Gralla R, Hainsworth J, Kris M, Anthony L, Khojasteh A, Tapazoglou E, Benedict C, Hahne W. J Clin Oncol; 1996 Aug; 14(8):2242-9. PubMed ID: 8708713 [Abstract] [Full Text] [Related]
34. Dolasetron, but not metoclopramide prevents nausea and vomiting in patients undergoing laparoscopic cholecystectomy. Piper SN, Suttner SW, Röhm KD, Maleck WH, Larbig E, Boldt J. Can J Anaesth; 2002 Dec; 49(10):1021-8. PubMed ID: 12477671 [Abstract] [Full Text] [Related]
35. A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapy. Audhuy B, Cappelaere P, Martin M, Cervantes A, Fabbro M, Rivière A, Khayat D, Bleiberg H, Faraldi M, Claverie N, Aranda E, Auclerc G, Audhuy B, Benhammouda A, Bleiberg H, Cals L, Cappelaere P, Cattan A, Cervantes A, Chevallier B, Conroy T, Cupissol D, De Grève J, Diaz-Rubio E, Seitz JF. Eur J Cancer; 1996 May; 32A(5):807-13. PubMed ID: 9081358 [Abstract] [Full Text] [Related]
36. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting. Gan TJ, Sinha AC, Kovac AL, Jones RK, Cohen SA, Battikha JP, Deutsch JS, Pergolizzi JV, TDS Study Group, Glass PS. Anesth Analg; 2009 May; 108(5):1498-504. PubMed ID: 19372328 [Abstract] [Full Text] [Related]
37. Antiemetic efficacy of two different single intravenous doses of dolasetron in patients receiving high-dose cisplatin-containing chemotherapy. Yeilding A, Bertoli L, Eisenberg P, Plezia P, Modiano MR, Alberts DS, Khojasteh A, Cramer MB, Hahne WF. Am J Clin Oncol; 1996 Dec; 19(6):619-23. PubMed ID: 8931684 [Abstract] [Full Text] [Related]
38. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups. Fortney JT, Gan TJ, Graczyk S, Wetchler B, Melson T, Khalil S, McKenzie R, Parrillo S, Glass PS, Moote C, Wermeling D, Parasuraman TV, Duncan B, Creed MR. Anesth Analg; 1998 Apr; 86(4):731-8. PubMed ID: 9539593 [Abstract] [Full Text] [Related]
39. Randomized comparison of two anti-emetic strategies in high-risk patients undergoing day-case gynaecological surgery. White H, Black RJ, Jones M, Mar Fan GC. Br J Anaesth; 2007 Apr; 98(4):470-6. PubMed ID: 17317757 [Abstract] [Full Text] [Related]
40. Dolasetron decreases postoperative nausea and vomiting after breast surgery. Abou Zeid H, Al-Gahamdi A, Abdul-Hadi M. Breast J; 2002 Apr; 8(4):216-21. PubMed ID: 12100113 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]